The Public’s Views on Measles Outbreaks and Misinformation
The Debate About Enhanced Premium Tax Credits Begins to Emerge (Finally)
Health Wonk Shop: Understanding Fraud, Abuse in Medicaid
How do state Medicaid programs ensure program integrity and what does it take to go after fraud? How substantial is fraud and abuse relative to total Medicaid spending? Join KFF’s Larry Levitt and three experts at 12 p.m. ET on Thursday, April 24, for a discussion that aims to answer these questions and more.
Latest News
-
Status of State Medicaid Expansion Decisions
This page displays an interactive map of the current status of state decisions on the Affordable Care Act’s Medicaid expansion. Additional Medicaid expansion resources are listed (with links) below the map.
-
Title X Clinics Affected by Administration’s Funding Freeze
Title X provides federal funding to support clinics across the country to provide comprehensive family planning services to low-income and uninsured individuals. On April 2, 2025, almost one in five of the current Title X grantees received notification that their year 4 funding of a 5-year project period would be temporarily withheld.
-
How Part of Drug Price EO Could Limit Medicare Drug Prices Negotiations
President Trump’s executive order directs the Secretary of HHS to work with Congress to implement a change in law to delay negotiation of so-called “small molecule” drugs under the IRA’s Medicare Drug Price Negotiation Program for an additional 4 years. We analyze how many of the drugs previously selected for negotiation would not have been eligible if this policy had been in place at the time.
-
Beyond the Data, a Column by Drew Altman
In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.